Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determine the Effect of Targeted High-definition tDCS on Reducing Post-stroke Upper Limb Motor Impairments

NCT05479006 is registered in ClinicalTrials.gov with Carle Foundation Hospital as lead sponsor.

NCT NCT05479006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05479006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determine the Effect of Targeted High-definition tDCS on Reducing Post-stroke Upper Limb Motor Impairments
Lead sponsor
Carle Foundation Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2022
Completion date
June 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke